Hideaki Kato

8.7k total citations
181 papers, 3.2k citations indexed

About

Hideaki Kato is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, Hideaki Kato has authored 181 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Infectious Diseases, 52 papers in Epidemiology and 34 papers in Hepatology. Recurrent topics in Hideaki Kato's work include Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (23 papers) and Liver Disease Diagnosis and Treatment (20 papers). Hideaki Kato is often cited by papers focused on Hepatitis C virus research (25 papers), Hepatitis B Virus Studies (23 papers) and Liver Disease Diagnosis and Treatment (20 papers). Hideaki Kato collaborates with scholars based in Japan, United States and Mexico. Hideaki Kato's co-authors include Masashi Mizokami, Ryuzo Ueda, Fuminaka Sugauchi, Etsuro Orito, Yuzo Miyakawa, Seiji Suzuki, Robert G. Gish, Hiroshi Sakugawa, Anuchit Chutaputti and Takafumi Ichida and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Hideaki Kato

169 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideaki Kato Japan 32 1.9k 1.5k 702 455 264 181 3.2k
Martine Dubois France 35 797 0.4× 1.9k 1.3× 1.3k 1.9× 400 0.9× 54 0.2× 88 3.7k
Jürgen J. Wenzel Germany 33 587 0.3× 1.8k 1.2× 1.6k 2.2× 367 0.8× 298 1.1× 124 3.2k
Giuseppe Di Pasquale Italy 30 1.1k 0.6× 866 0.6× 141 0.2× 394 0.9× 553 2.1× 154 2.9k
R. Orlando Italy 30 637 0.3× 762 0.5× 180 0.3× 421 0.9× 1.3k 5.0× 136 3.3k
Ajit Sood India 35 2.3k 1.2× 938 0.6× 694 1.0× 942 2.1× 1.3k 5.0× 216 4.5k
Cecilia M. Shikuma United States 35 959 0.5× 233 0.2× 2.3k 3.2× 344 0.8× 197 0.7× 156 4.2k
U. Bode Germany 40 722 0.4× 319 0.2× 376 0.5× 1.2k 2.6× 509 1.9× 140 5.0k
Aruna Subramanian United States 24 818 0.4× 215 0.1× 1.4k 2.0× 544 1.2× 338 1.3× 73 2.8k
Hannelie Korf Belgium 31 1.2k 0.6× 191 0.1× 705 1.0× 731 1.6× 587 2.2× 70 4.2k
Santino Marchi Italy 43 903 0.5× 617 0.4× 349 0.5× 279 0.6× 2.8k 10.5× 194 5.2k

Countries citing papers authored by Hideaki Kato

Since Specialization
Citations

This map shows the geographic impact of Hideaki Kato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideaki Kato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideaki Kato more than expected).

Fields of papers citing papers by Hideaki Kato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideaki Kato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideaki Kato. The network helps show where Hideaki Kato may publish in the future.

Co-authorship network of co-authors of Hideaki Kato

This figure shows the co-authorship network connecting the top 25 collaborators of Hideaki Kato. A scholar is included among the top collaborators of Hideaki Kato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideaki Kato. Hideaki Kato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sakurai, Aki, Masahiro Suzuki, Ryota Hase, et al.. (2026). In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in Japan. Journal of Infection and Chemotherapy. 32(2). 102905–102905.
2.
Kato, Hideaki, et al.. (2025). Identification of Putative Serum Autoantibodies Associated with Post-Acute Sequelae of COVID-19 via Comprehensive Protein Array Analysis. International Journal of Molecular Sciences. 26(4). 1751–1751. 2 indexed citations
4.
Sano, Kaori, Kei Miyakawa, Hideaki Kato, et al.. (2025). Neutralizing antibody evasion of SARS-CoV-2 JN.1 derivatives KP.3, KP.3.1.1, LB.1, and XEC. Vaccine. 62. 127472–127472. 1 indexed citations
5.
Sano, Kaori, Yayoi Kimura, Atsushi Goto, et al.. (2024). Cellular and humoral immunity and IgG subclass distribution after omicron XBB.1.5 monovalent vaccination in Japan. Vaccine. 42(26). 126452–126452. 1 indexed citations
6.
Hayakawa, Kayoko, Tohru Miyoshi‐Akiyama, Norihiko Takemoto, et al.. (2024). Comparison of the effects of cefmetazole and meropenem on microbiome: A pilot study. Journal of Infection and Chemotherapy. 30(12). 1274–1279. 1 indexed citations
7.
Kato, Hideaki, et al.. (2023). Comparing the Dosing Period in Package Inserts of Antimicrobial Agents Between Japan and the United States. Cureus. 15(4). e38266–e38266. 1 indexed citations
8.
Tanaka, Miho, et al.. (2023). Effects of a smartphone app‐based diet and physical activity program for men living with HIV who have dyslipidemia: A pilot randomized controlled trial. Japan Journal of Nursing Science. 20(3). e12535–e12535. 4 indexed citations
9.
Yamagishi, Takuya, et al.. (2022). SARS-CoV-2 Delta AY.1 Variant Cluster in an Accommodation Facility for COVID-19: Cluster Report. International Journal of Environmental Research and Public Health. 19(15). 9270–9270.
10.
Samukawa, Seiji, Ryusuke Yoshimi, Kaoru Takase‐Minegishi, et al.. (2022). Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report. Journal of Infection and Chemotherapy. 29(3). 347–352. 2 indexed citations
11.
Miyakawa, Kei, Sundararaj Stanleyraj Jeremiah, Yutaro Yamaoka, et al.. (2021). Persistence of Robust Humoral Immune Response in Coronavirus Disease 2019 Convalescent Individuals Over 12 Months After Infection. Open Forum Infectious Diseases. 9(2). ofab626–ofab626. 5 indexed citations
12.
Kato, Hideaki, et al.. (2015). Blind Sac Closure of the External Ear Canal in Cochlear Implant Surgery. Practica Oto-Rhino-Laryngologica. 108(10). 755–761.
13.
Hirano, Yasumitsu, et al.. (2012). A case of primary early appendiceal carcinoma detected by perforation of appendiceal diverticulum. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 73(5). 1144–1148. 3 indexed citations
14.
Kato, Hideaki, Kazuaki Takahashi, Makoto Nakamura, et al.. (2011). Two cases of acute hepatitis E due to Aichi/Shizuoka strain developed after intake of wild boar meat. Kanzo. 52(8). 524–527. 3 indexed citations
15.
Kato, Hideaki, et al.. (2010). Acute Exacerbation of Liver Disease Induced by Pegylated Interferon Alpha2a Treatment for Chronic Hepatitis C. International Journal of Clinical Medicine. 1(1). 1–5. 2 indexed citations
16.
Kato, Hideaki, et al.. (2009). A CASE OF INTERNAL HERNIA IN THE MESENTERY OF THE TRANSVERSE COLON. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 70(9). 2876–2880. 5 indexed citations
17.
Kato, Hideaki, et al.. (2009). Rapid analysis of Clostridium difficile strains recovered from hospitalized patients by using the slpA sequence typing system. Journal of Infection and Chemotherapy. 15(3). 199–202. 8 indexed citations
18.
Kato, Hideaki, et al.. (2009). Rupture of a Splenic Pseudoaneurysm into the Transverse Colon. The Japanese Journal of Gastroenterological Surgery. 42(4). 394–398.
19.
Sugauchi, Fuminaka, Etsuro Orito, Takafumi Ichida, et al.. (2003). Epidemiologic and virologic characteristics of hepatitis B virus genotype B having the recombination with genotype C. Gastroenterology. 124(4). 925–932. 171 indexed citations
20.
Takimoto, Toru, et al.. (1993). Transrectal Administration of Thyroid Hormone after Total Laryngopharyngectomy and Thyroidectomy.. Practica Oto-Rhino-Laryngologica. 86(1). 103–108. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026